Hebei Changshan Biochemical Pharmaceutical Co (SZSE:300255) YoY Rev. per Sh. Growth : -12.50% (As of Mar. 2025)

View and export this data going back to 2011. Start your Free Trial

What is Hebei Changshan Biochemical Pharmaceutical Co YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Hebei Changshan Biochemical Pharmaceutical Co's YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2025 was -12.50%.

Hebei Changshan Biochemical Pharmaceutical Co's Revenue per Share for the three months ended in Mar. 2025 was ¥0.28.

Hebei Changshan Biochemical Pharmaceutical Co YoY Rev. per Sh. Growth Historical Data

The historical data trend for Hebei Changshan Biochemical Pharmaceutical Co's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hebei Changshan Biochemical Pharmaceutical Co YoY Rev. per Sh. Growth Chart

Hebei Changshan Biochemical Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

YoY Rev. per Sh. Growth

Get a 7-Day Free Trial

14.36

25.87

-16.02

-42.47

-27.30

Hebei Changshan Biochemical Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
YoY Rev. per Sh. Growth	Get a 7-Day Free Trial															-40.96	-18.52	-12.65	-11.30	-12.50

Hebei Changshan Biochemical Pharmaceutical Co YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Hebei Changshan Biochemical Pharmaceutical Co's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2024 is calculated as:

	YoY Rev. per Sh. Growth (A: Dec. 2024 )
=	(Revenue per Share (A: Dec. 2024 )	-	Revenue per Share (A: Dec. 2023 ))	/	\| Revenue per Share (A: Dec. 2023 ) \|
=	(1.116	-	1.535)	/	\| 1.535 \|
=	-27.30 %

Hebei Changshan Biochemical Pharmaceutical Co's YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2025 is calculated as:

	YoY Rev. per Sh. Growth (Q: Mar. 2025 )
=	(Revenue per Share (Q: Mar. 2025 )	-	Revenue per Share (Q: Mar. 2024 ))	/	\| Revenue per Share (Q: Mar. 2024 )) \|
=	(0.28	-	0.32)	/	\| 0.32 \|
=	-12.50 %

Hebei Changshan Biochemical Pharmaceutical Co YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Hebei Changshan Biochemical Pharmaceutical Co's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Hebei Changshan Biochemical Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hebei Changshan Biochemical Pharmaceutical Co Ltd (SZSE:300255) » Definitions » YoY Rev. per Sh. Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

North of Yinchuan Street, Zhengding New District, Hebei, Shijiazhuang, CHN, 050800

Website

http://www.hbcsbio.com

Hebei Changshan Biochemical Pharmaceutical Co Ltd is a biotech high-tech enterprise. It is mainly engaged in the research, development, production, and sale of heparin series products. Some of the company's products are Reserpine sodium, Hyaluronic acid, Heparinoid, Heparin sodium, Tinzaparin sodium, Aspirin enteric-coated tablets, and Yihaitang.

Executives

Li Zhi Hua	Executives
Wang Jun	Executives
Ding Jian Wen	Directors, executives
Huang Guo Sheng	Executives
Gao Shu Hua	Directors, executives
Chen Xi	Director
Cai Hao	Executives
Ji Sheng Li	Directors, executives
Li Xin	Securities Affairs Representative
Zhang Wei	Secretary Dong
Liu Jian	Executives
Zhang Zhi Ying	Executives
Guo Yan Xing	Supervisors

Hebei Changshan Biochemical Pharmaceutical Co Headlines

No Headlines